Best Life Sciences Companies in Utrecht, Netherlands
The 73 best Life Sciences companies in Utrecht, Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Merus.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Utrecht
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Merus Developer of antibody-based drugs for cancer treatment | $156M | 90 mo ago | 221 | — | WordPressApple iCloud MailMicrosoft 365+22 | 1,027 patents Bispecific antibody therapeutics targeting cancer and immune checkpoints for oncology applications. | — |
| 2 | Kaleido Developer of insulin therapy for treating diabetes | $85M | 5 mo ago | 129 | Tim Oakes Co-Founder & CTO | WordPressMySQLPHP+31 | — | 3 launchs · 1 partnership |
| 3 | Vitestro Developed AI-based blood drawing robot for clinic use 69Funding top 23%Growth top 28%Moat top 35%Talent top 38% All 9 signals ▾Fundingtop 23% Growthtop 28% Moattop 35% Talenttop 38% Newstop 43% Techtop 44% AItop 45% Marketbottom 46% Globalbottom 36% Funding: Raised $50.0M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 69/100 | $50M | 3 mo ago | 50 | Toon Overbeeke Co-Founder & CEO | WordPressMySQLPHP+25 | — | — |
| 4 | TargED Developer of biological drugs for the treatment of thrombosis | $46M | 6 mo ago | 17 | Steven Maat Co-Founder | WordPressMySQLPHP+15 | — | 2 job openings |
| 5 | Bilthoven Biologicals Large scale vaccines manufacturer for infectious diseases, such as polio and tetanus | $29M | 35 mo ago | 371 | Jan-Eric Zandbergen CEO | WordPressMySQLPHP+15 | — | 2 partnerships |
| 6 | Xpand Biotechnology Developer of alternative bio-reactors for 2D cell culture | $17M | 107 mo ago | 15 | Joost De Bruijn Founder | — | 19 patents Single-use bioreactors with pH/gas control and osteoinductive calcium‑phosphate biomaterials | — |
| 7 | SentryX Developer of therapeutics for pain treatment after surgery | $17M | 38 mo ago | 20 | Bas Oosterman Co-Founder and CEO | TurbopackNode.jsReact+11 | 44 patents Pharmaceutical gelatin purification and gelatin-based hydrogel drug delivery technologies | 1 award |
| 8 | AMT Medical Providing solutions for heart bypass surgery | $12M | 14 mo ago | 21 | Rutger Tulleken CEO | WordPressMySQLPHP+24 | 11 patents Vascular surgical clips and anastomosis connectors for blood vessel joining | — |
| 9 | Gadeta T Cell based cancer therapies based on gamma delta (γδ) T cell receptors | $8M | 66 mo ago | 31 | — | — | 61 patents Engineered gamma‑delta T‑cell receptors and cell therapies for cancer and infection | — |
| 10 | Encare Biotech Specialty company developing a new therapeutic antibody for the prevention of heart failure after acute… | $7M | 139 mo ago | — | MARK BOER CEO | — | 13 patents Therapeutic antibodies targeting fibronectin-EDA for anti‑fibrotic and inflammatory treatment | — |
| 11 | Prolira Developer of a non-invasive device for the early detection of delirium | $6M | 52 mo ago | 12 | Rutger Van Merkerk Co-Founder & CEO | — | 17 patents EEG electrode carriers and signal segmentation/classification systems for neurodiagnostic monitoring | — |
| 12 | FF Pharma MAbs for inflammatory diseases like primary biliary cirrhosis and Crohn’s disease | $5M | 161 mo ago | — | Mark de Boer CEO | — | 151 patents Therapeutic recombinant alkaline phosphatase enzymes for kidney injury and sepsis treatment | — |
| 13 | Scinus Developer of closed-system bioreactors for cell therapy production | $3M | 3 mo ago | 8 | — | — | — | 1 internship · 1 partnership |
| 14 | MRIguidance Provider of MRI based bone diagnostic platform | $3M | 57 mo ago | 22 | Roel Raatgever Co-Founder & CEO | WordPressMySQLPHP+21 | 12 patents MRI-derived synthetic CT imaging and quantitative bone volume assessment for medical diagnostics. | 3 job openings · 1 partnership |
| 15 | Cergentis Provider of kits and services for the targeted sequencing of genes | $3M | 73 mo ago | 39 | — | — | 41 patents 3D genome region sequencing and targeted copy-number heterogeneity analysis | — |
| 16 | Apo-T Dutch, private, biopharma company developing antibody-drug conjugates and apoptosis-inducers for cancer… | $3M | 146 mo ago | — | dr Willemsen Founder | — | 67 patents Bispecific immunotherapeutic agents directing immune cells to tumor antigens | — |
| 17 | MILabs Develops Imaging Instruments for clinical and pre-clinical applications | $3M | 116 mo ago | 48 | — | WordPressMySQLPHP+31 | 82 patents Advanced nuclear medical imaging hardware—gamma cameras, SPECT scanners, X‑ray systems, and collimators. | — |
| 18 | Cleara Developer of biomarkers and therapies to treat cancer and aging diseases | $2M | 44 mo ago | 10 | Marco Demaria Co-Founder | WordPressMySQLPHP+12 | — | — |
| 19 | Guideways AI agents automate medtech approval and maintenance processes for faster market access. | $1M | 7 mo ago | — | Sander Denissen CEO | — | — | — |
| 20 | Core Life Analytics Provider of a cloud-based data analytics solutions for life sciences | $1M | 72 mo ago | 10 | David Egan Co-Founder & CEO | Linkedin Insight TagGoogle AnalyticsCloudflare Browser Insights+8 | — | — |
| 21 | Cavadis Developing medical prognostic tests for heart attack and stroke | $687K | 196 mo ago | — | Heico Breek CEO | — | 16 patents Exosome-based liquid biopsy diagnostics for cardiovascular risk prediction | — |
| 22 | CryoCloud Provider of cloud-based platform for Cryo-EM data analysis | $541K | 13 mo ago | — | Robert Englmeier Co-Founder & CEO | SanityNode.jsReact+10 | — | 2 launchs |
| 23 | DC4U Glycan based technology for immunotherapeutics | $455K | 74 mo ago | 2 | Henk Vietor CEO | — | — | — |
| 24 | Hercules Developer of Aryl Hydrocarbon Receptor inhibiting drug for Triple Negative Breast Cancer treatment | $354K | 70 mo ago | 2 | — | — | 20 patents Patents concentrated in textiles | — |
| 25 | MicroDish Developer of microchips and reagents for microbial cell culture | $282K | 115 mo ago | 4 | Colin Ingham Founder & CSO | — | 5 patents Rapid bacterial detection methods and microbial growth chamber technologies | — |
| 26 | Triall Provider of blockchain-based platform for clinical ecosystem | $200K | 56 mo ago | 19 | — | — | — | — |
| 27 | FormsVision Clinical development solutions and tools for clinical trials | $165K | 64 mo ago | — | Emile van der Donk Co-Founder & CEO | — | — | — |
| 28 | IDfuse Provider of tool for writing grant proposals | $121K | 69 mo ago | — | Tijmen Altena Co-Founder & Owner | — | — | — |
Top 12 Life Sciences companies in Utrecht
#1
Series B · Utrecht, Utrecht · founded 2017 · 50 employees$50Mraised▾
Developed AI-based blood drawing robot for clinic use. The company has developed a medical robotics device that autonomously draws blood from patients. The device has a guided 3D construction with a robotic needle that secures blood collection. It has features for bandage application as well.
- Mar 2026Series B$70M
- Apr 2024Series A$22M
- Mar 2023Grant (prize money)—
- Mar 2023Series A$12.9M
#2
Series D · Utrecht, Utrecht · founded 2013 · 129 employees$85.3Mraised▾
Hello Kaleido develops an insulin pump for treating diabetes. It is a medical device used for the administration of insulin in the treatment of diabetes mellitus. It uses a Bluetooth channel to connect with the phone which reminds users of insulin administration. The company also provides software for diabetic monitoring.
- Jan 2026Series D$13M
- Sep 2025Series D$85M
- Dec 2021Series C$74M
- Jun 2020Series B$11.3M
#3
Series A · Utrecht, Utrecht · founded 2020 · 17 employees$45.8Mraised▾
Developer of biological drugs for the treatment of thrombosis. The company offers its FDA-approved biological drugs and TargED Targeted Enzyme Delivery system which is a small antibody that can target the specific sites of thrombosis and enable the blood flow to reduce the risk for organ failure is reduced. The company target Thrombotic thrombocytopenic purpura (TTP) and Acute Ischemic Stroke (AIS) and the lead compound Microlyse is a thrombolytic fusion protein that consisting two subunits i.e a nanobody domain targeting Von Willebrand Factor (VWF) which helps in wound healing also and the protease domain of the plasminogen activator urokinase. It targets the protease domain towards VWF, to active degradation of both VWF and fibrin.
- Dec 2025Series A$25.2M
- Jul 2025Grant (prize money)$2.9M
- Jul 2025Series A$11.8M
- Feb 2022Series A$44.2M
#4
Series A · Bilthoven, Utrecht · founded 2016 · 8 employees$3.5Mraised▾
Developer of closed-system bioreactors for cell therapy production. It provides a cost-effective solution for cultivating clinically relevant cell numbers. The bioreactor system supports both research and development and Good Manufacturing Practice (GMP) processes. Utilizing single-use bags, it offers scalability for large-fold cell expansion. The system is adaptable for both adherent and suspension cell types, using a unique rocking platform to ensure optimal culture conditions. Development included extensive biological process development for various cell types, including mesenchymal stromal cells and induced pluripotent stem cells. The company's technology aims to improve cell therapy and regenerative medicine.
- Mar 2026Series A$3.4M
- Feb 2019Grant (prize money)$36.9K
#5
Series B · Utrecht, Utrecht · founded 2016 · 21 employees$11.7Mraised▾
AMT MEDICAL is providing solutions for heart bypass surgery. Its AMT technology is based on total endoscopy coronary artery bypass surgery. With the use of a connector, laser catheter, and a small robot they make a small opening in the chest to perform surgery.
- Apr 2025Series B$25M
- Sep 2020Series A$11.7M
- Sep 2019Grant (prize money)$436.6K
- Grant (prize money)—
#6
Seed · Utrecht, Utrecht · founded 2024$1.2Mraised▾
AI agents automate medtech approval and maintenance processes for faster market access. The company develops AI agents that streamline regulatory approval, post-market surveillance, quality management, and reimbursement processes for medical devices and software-as-medical devices. The AI analysis provides insights, and the platform facilitates connections with domain experts. The focus is on accelerating time to market and reducing maintenance costs for health technology companies.
- Nov 2025Seed$1.2M
#7
Seed · Utrecht, Utrecht · founded 2021$541.4Kraised▾
Provider of cloud-based platform for Cryo-EM data analysis. It offers web-based application that provides researhers access to cloud resources, image analysis workflows and storage solutions for cryo-EM data analysis of protein structure.
- May 2025Seed$2.3M
- Oct 2023Seed$528.4K
#8
Acquired · Bilthoven, Utrecht · founded 2012 · 371 employees$28.6Mraised▾
Bilthoven Biologicals produces large scale vaccines for infectious diseases, such as polio and tetanus. It was acquired by Poonawalla Group (Serum Institute, Indian vaccine manufacturer) in Jul.2012. The company manufacturers more than 20M vaccine units each year and sells in more than 25 countries.
- Jun 2023Grant (prize money)$28.6M
#9
Acquired · Utrecht, Utrecht · founded 2003 · 221 employees$156.2Mraised▾
Developer of antibody-based drugs for cancer treatment. The company develops products using bispecific antibody engineering and advanced screening technologies that engage the power of the immune system to kill cancer cells. Its products include Zenocutuzomab, Petosemtamab, and MCLA-145 for lung, pancreatic and other cancers.
- Dec 2018Post IPO$15M
- Feb 2018Post IPO$55.8M
- Jan 2017Post IPO$80M
- Nov 2016Grant (prize money)—
#10
Funding Raised · Woudenberg, Utrecht · founded 2017 · 20 employees$16.7Mraised▾
Developer of therapeutics for pain treatment after surgery. The company's lead product BR-003 is a highly elastic and biodegradable hydrogel designed to be attached to commercially available screws used in spinal surgery.
- Apr 2023Grant (prize money)$16.7M
#11
Acquired · Bilthoven, Utrecht · founded 2004 · 15 employees$17.1Mraised▾
Xpand biotech has developed mini-bioreactors for cell culture as an alternative to the 2D cell culture system. Also, the company has used the system to study regenerative medicine, with a focus on bone tissue regeneration using calcium phosphate-based material, that has osteoconductive properties.
- Jun 2017Grant (prize money)$2.1M
- Jan 2017Grant (prize money)$1.1M
- Jul 2015Grant (prize money)$2M
- Feb 2007Grant (prize money)$7.1M
#12
Series B · Utrecht, Utrecht · founded 2015 · 12 employees$5.7Mraised▾
Developer of a non-invasive device for the early detection of delirium. The company offers an EEG-based device that consists of a single-use electrode patch and a hardware/software module that analyses brain activity.
- Feb 2022Series B$5.7M
- Nov 2018Series A—
- Jul 2018Grant (prize money)$2.8M
- Sep 2016Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Utrecht is moving
A read on the academic research around Biotechnology in Utrecht — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 75 papers.
- Utrecht University59
- University Medical Center Utrecht20
- University of Applied Sciences Utrecht5
- Gene2
- Induced pluripotent stem cell2
- Cell culture2
- HEK 293 cells2
- Intracellular2
- Microbiome3
- Soil water2
- Agriculture2
- Organoid1
- Crypt1
- Rhizosphere1
- Context (archaeology)1
- Agriculture1
- Microorganism1
- Microbiome1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.